Ceapro Inc V.CZO

Not one comment in favor of the merger...

[prophetoffactz]

Given that there was no mention that CZO's main client has returned in the Information Circular(that I'm aware of) and that CZO had ~$11 million cash at the end of September how much cash will be left by the vote? That will be about 5 1/2 months. They never mentioned the current cash in the Information Circular which could be an issue. Since September 30, 2023 CZO needed cash to cover the costs of the proposed merger, the ramp up of the avenanthramide clinical trial, and the simultaneous 5X and 10X scale-up of PGX including with Natex. The additional studies with the Angiogenesis Foundation were also said to be ongoing and they may have begun the toxicology study for the fibrosis drug. There's also a $500,000 breakup fee for the merger but I'm not sure of the conditions. How much cash will CZO have left by the vote? People here like to talk about delays so what if there are delays with PGX scale-up? Are people proposing a financing with warrants and if shareholders have not been willing to listen to the universal recommendation of the Board of Directors and Special Committee and derail this deal who will want to do a financing? The costs of trying to put this merger together have been significant are people suggesting another round or costs and if shareholders don't listen to the Board could that make deal shopping risky? Will the company be in need of additional capital to move things forward and in the penalty box due to the failed deal? On the other hand the AEZS deal provides financing without warrants and fully finances CZO's near term revenue generating prospects. CZO could get to work after the merger closes without further delay.

[lscfa]

Upon learning of Symrise and Kenvue developments, CZO should have immediately implemented an austerity plan. Spending on all pie-in-the sky BS projects should have be halted, salaries cut back and all attention should have been on the core business. Gagnon is an idiot.

[jrsloan60]

If this was good for Ceapro the shares would be going up with some volume. 

[prophetoffactz]

It's two off-the-radar microcaps with retail shareholder bases. Look at CZO's message board as an example. There isn't much interest in the science yet this is a biopharma. The specific product plan, priorities, and burnrate for the new company to specific product revenue is not clear. There is a history of loses with AEZS. Mergers come with their own risks. If the merger doesn't

[Ciao]

And if it was good for AEZS it would be going up with volume as well, instead both stocks have dropped about 30% since the annoucement. Exciting times for valued shareholders. "If your claim to fame is that you've taken money from other people and not delivered what you promised, that doesn't make you a genius business man, that makes you a crook" ...this was said by Kathy Duva

[jrsloan60]

Question I have why do CEOs make so much money if they can't accomplish any goals. I see the merger of two companies that eroded massive amounts of shareholder value. And accomplishing nothing. I was at the meeting when they announced the pharmaceutical upgrade of the plant being built in Edmonton. I thought that was a great idea. So I bought more shares at $0.20. now they're selling at 16

[Ciao]

For those that gave Gilles the benefit of the doubt (including myself) for many years and thought that he finally got the help he needed with the new hires in 2022 to help him execute, we now know it was all a ruse. It bought him time so he wouldn't be voted off the board.

[tigerpro]

Correct. Gilles is a liar.  We shareholders need to do whatever we can to remove him as CEO. Vote No first, then remove him.  This is the only way to save Ceapro.

[Apostata]

I belong to this same cohort: the people who, until the promises became threadbare, gave Gilles the benefit of the doubt.  No more.  Fcuk these clowns. 

[Hopeforthebest]

Proph wrote - savings from streamlining the two businesses by eliminating the TSX-V listing, having one CFO, etc., as opposed to two, and having one IR function, etc.   Well guess what proph, we get the same by voting NO, 1 CEO who will not be getting $960,000 in consulting fees, a BoD or less than 10, one IR function that actually functions and best of all we get a company

[PBaelishh]

AEZS has the same useless IR - Jenene Thomas!!!  How incestuous is this?!!! Nothin' but little suckling pigglets, everywhere.

[prophetoffactz]

"Question I have why do CEOs make so much money if they can't accomplish any goals." Everything is still in place and with the merger CZO's near-term revenue generating pipeline is expected to be fully financed. The merger established an exchange ratio but the ultimate value of the merged company will only be determined upon events. Gilles is inside both companies and has Ronnie

[prophetoffactz]

Concerning the burn rate of the proposed company in addition to the savings from streamlining the two businesses by eliminating the TSX-V listing, having one CFO, etc., as opposed to two, and having one IR function, etc., the new company will evaluate the pipeline and prioritize assets. Perhaps some will be eliminated reducing the burn rate and directing more cash to the highest priority assets